Roupen Odabashian, Oncologist at Abbotsford Regional Hospital and Cancer Centre, Founder of MeDucation AI, Podcast Host at OncoDaily, shared on LinkedIn:
“We are releasing free AI tumor board by MeDucation AI.
Paste a de-identified oncology case and nine specialist AI agents will research it against live PubMed and ClinicalTrials.gov, argue with each other, and hand you a citation grounded consensus in about five minutes. It is free and there is no account.
The panel convenes based on the case. Medical oncology, hematology, radiation oncology, surgical oncology, molecular, pathology, transplant and cellular therapy, trial matching. The clinical pharmacist is always on as a safety gate, which was a deliberate choice: interactions and dosing are where an LLM quietly hurts someone.
Two design decisions I care about more than the agent count.
- Every clinical claim has to carry a citation from a live source, so fabricated references are structurally impossible rather than merely discouraged.
- A judge scores consensus and opens another round when the panel disagrees, so you see the disagreement instead of a smoothed over answer.
Cases run in memory and expire within thirty minutes. No accounts, no storage. Still, do not paste identifiers. Synthetic and educational cases only.
This is a free research preview and it is for research and education, not medical advice. It does not replace your institutional tumor board and it is not reviewed by a physician.
If you run a case, I want to know where it was wrong. That is more useful to me than knowing where it was right.”
Other articles about Roupen Odabashian on OncoDaily.